Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.63
ABC's Cash to Debt is ranked higher than
59% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.63 vs. ABC: 0.63 )
ABC' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 0.63

Equity to Asset 0.10
ABC's Equity to Asset is ranked lower than
65% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.38 vs. ABC: 0.10 )
ABC' s 10-Year Equity to Asset Range
Min: -0.36   Max: 0.38
Current: 0.1

-0.36
0.38
Interest Coverage 11.97
ABC's Interest Coverage is ranked higher than
64% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.68 vs. ABC: 11.97 )
ABC' s 10-Year Interest Coverage Range
Min: 2.72   Max: 60.07
Current: 11.97

2.72
60.07
F-Score: 5
Z-Score: 6.16
M-Score: -2.13
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 1.02
ABC's Operating margin (%) is ranked lower than
60% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.78 vs. ABC: 1.02 )
ABC' s 10-Year Operating margin (%) Range
Min: 1.02   Max: 1.78
Current: 1.02

1.02
1.78
Net-margin (%) 0.49
ABC's Net-margin (%) is ranked lower than
60% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.78 vs. ABC: 0.49 )
ABC' s 10-Year Net-margin (%) Range
Min: 0.36   Max: 0.9
Current: 0.49

0.36
0.9
ROE (%) 18.70
ABC's ROE (%) is ranked higher than
94% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. ABC: 18.70 )
ABC' s 10-Year ROE (%) Range
Min: 4.41   Max: 317.48
Current: 18.7

4.41
317.48
ROA (%) 2.29
ABC's ROA (%) is ranked higher than
52% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.39 vs. ABC: 2.29 )
ABC' s 10-Year ROA (%) Range
Min: 1.22   Max: 4.72
Current: 2.29

1.22
4.72
ROC (Joel Greenblatt) (%) 111.80
ABC's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 34.71 vs. ABC: 111.80 )
ABC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.15   Max: 161.81
Current: 111.8

13.15
161.81
Revenue Growth (%) 11.30
ABC's Revenue Growth (%) is ranked higher than
74% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.50 vs. ABC: 11.30 )
ABC' s 10-Year Revenue Growth (%) Range
Min: 7.9   Max: 28.5
Current: 11.3

7.9
28.5
EBITDA Growth (%) 2.70
ABC's EBITDA Growth (%) is ranked higher than
52% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.60 vs. ABC: 2.70 )
ABC' s 10-Year EBITDA Growth (%) Range
Min: -6.3   Max: 27
Current: 2.7

-6.3
27
EPS Growth (%) -1.80
ABC's EPS Growth (%) is ranked higher than
54% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. ABC: -1.80 )
ABC' s 10-Year EPS Growth (%) Range
Min: -8   Max: 36.2
Current: -1.8

-8
36.2
» ABC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

ABC Guru Trades in Q3 2013

Jim Simons 470,000 sh (New)
Ray Dalio 45,889 sh (+65.99%)
Steven Cohen 15,317 sh (+42.47%)
Ken Fisher 266,703 sh (+3.34%)
John Keeley 91,863 sh (-24.14%)
Jeremy Grantham 353,374 sh (-34.01%)
Larry Robbins 1,425,876 sh (-34.47%)
Joel Greenblatt 3,543 sh (-95.6%)
» More
Q4 2013

ABC Guru Trades in Q4 2013

Steven Cohen 24,457 sh (+59.67%)
Jim Simons Sold Out
Joel Greenblatt Sold Out
Larry Robbins Sold Out
John Keeley 89,490 sh (-2.58%)
Ken Fisher 189,305 sh (-29.02%)
Jeremy Grantham 76,832 sh (-78.26%)
Ray Dalio 5,289 sh (-88.47%)
» More
Q1 2014

ABC Guru Trades in Q1 2014

Louis Moore Bacon 6,132 sh (New)
Paul Tudor Jones 13,509 sh (New)
Joel Greenblatt 6,078 sh (New)
Ray Dalio 29,089 sh (+449.99%)
Ken Fisher 183,543 sh (-3.04%)
John Keeley 77,330 sh (-13.59%)
Steven Cohen 16,574 sh (-32.23%)
Jeremy Grantham 38,500 sh (-49.89%)
» More
Q2 2014

ABC Guru Trades in Q2 2014

Jim Simons 5,200 sh (New)
Ken Fisher 183,657 sh (+0.06%)
Jeremy Grantham Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
Ray Dalio Sold Out
Joel Greenblatt Sold Out
John Keeley 76,984 sh (-0.45%)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2014-06-30 Sold Out 0.02%$62.83 - $73.66 $ 76.8612%0
Joel Greenblatt 2014-06-30 Sold Out 0.01%$62.83 - $73.66 $ 76.8612%0
Ray Dalio 2014-03-31 Add 449.99%0.01%$64.11 - $71.38 $ 76.8613%29089
Joel Greenblatt 2014-03-31 New Buy0.01%$64.11 - $71.38 $ 76.8613%6078
Ray Dalio 2013-12-31 Reduce -88.47%0.02%$61.19 - $70.89 $ 76.8614%5289
Joel Greenblatt 2013-12-31 Sold Out 0.01%$61.19 - $70.89 $ 76.8614%0
Joel Greenblatt 2013-09-30 Reduce -95.6%0.18%$54.83 - $62.23 $ 76.8632%3543
John Keeley 2013-09-30 Reduce -24.14%0.03%$54.83 - $62.23 $ 76.8632%91863
Ray Dalio 2013-09-30 Add 65.99%0.01%$54.83 - $62.23 $ 76.8632%45889
John Hussman 2013-06-30 Sold Out 0.19%$51.64 - $56.3 $ 76.8642%0
Ray Dalio 2013-06-30 Reduce -58.27%0.02%$51.64 - $56.3 $ 76.8642%27645
John Hussman 2013-03-31 New Buy0.19%$43.18 - $51.45 $ 76.8664%100000
John Keeley 2013-03-31 New Buy0.14%$43.18 - $51.45 $ 76.8664%139667
Joel Greenblatt 2013-03-31 Reduce -22.53%0.07%$43.18 - $51.45 $ 76.8664%92842
Ray Dalio 2013-03-31 Reduce -39.33%0.02%$43.18 - $51.45 $ 76.8664%66255
John Keeley 2012-12-31 Sold Out 0.16%$39.03 - $43.91 $ 76.8687%0
Ray Dalio 2012-12-31 Reduce -46.47%0.05%$39.03 - $43.91 $ 76.8687%109210
John Keeley 2012-09-30 Reduce -65.63%0.32%$37.36 - $39.78 $ 76.8699%185401
John Keeley 2012-06-30 Reduce -26.38%0.16%$35.7 - $39.61 $ 76.86106%539491
Ray Dalio 2012-06-30 Reduce -24.62%0.05%$35.7 - $39.61 $ 76.86106%248910
John Keeley 2012-03-31 Reduce -25.12%0.19%$36.19 - $40.09 $ 76.86117%732766
Joel Greenblatt 2012-03-31 Add 76.09%0.19%$36.19 - $40.09 $ 76.86117%128834
Ray Dalio 2012-03-31 Add 103.82%0.1%$36.19 - $40.09 $ 76.86117%330210
Joel Greenblatt 2011-12-31 Add 106.08%0.17%$35.57 - $42.08 $ 76.86103%73162
Ray Dalio 2011-12-31 New Buy0.1%$35.57 - $42.08 $ 76.86103%162010
Joel Greenblatt 2011-09-30 Add 23.76%0.04%$34.63 - $43.09 $ 76.8696%35502
Ray Dalio 2011-09-30 Sold Out 0.01%$34.63 - $43.09 $ 76.8696%0
Joel Greenblatt 2011-06-30 Reduce -24.14%0.11%$39.5 - $42.44 $ 76.8687%28687
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 71.10
ABC's P/E(ttm) is ranked lower than
55% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.00 vs. ABC: 71.10 )
ABC' s 10-Year P/E(ttm) Range
Min: 11.12   Max: 71.2
Current: 71.1

11.12
71.2
P/B 8.70
ABC's P/B is ranked lower than
71% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.30 vs. ABC: 8.70 )
ABC' s 10-Year P/B Range
Min: 1.24   Max: 8.78
Current: 8.7

1.24
8.78
P/S 0.16
ABC's P/S is ranked higher than
93% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.54 vs. ABC: 0.16 )
ABC' s 10-Year P/S Range
Min: 0.07   Max: 0.2
Current: 0.16

0.07
0.2
PFCF 50.30
ABC's PFCF is ranked higher than
58% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.85 vs. ABC: 50.30 )
ABC' s 10-Year PFCF Range
Min: 3.51   Max: 50.52
Current: 50.3

3.51
50.52
EV-to-EBIT 26.14
ABC's EV-to-EBIT is ranked higher than
56% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.68 vs. ABC: 26.14 )
ABC' s 10-Year EV-to-EBIT Range
Min: 6   Max: 26.5
Current: 26.14

6
26.5
PEG 6.70
ABC's PEG is ranked higher than
60% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.46 vs. ABC: 6.70 )
ABC' s 10-Year PEG Range
Min: 0.45   Max: 29.93
Current: 6.7

0.45
29.93
Shiller P/E 35.10
ABC's Shiller P/E is ranked higher than
67% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 100.50 vs. ABC: 35.10 )
ABC' s 10-Year Shiller P/E Range
Min: 13.76   Max: 35.32
Current: 35.1

13.76
35.32
Current Ratio 0.97
ABC's Current Ratio is ranked lower than
65% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. ABC: 0.97 )
ABC' s 10-Year Current Ratio Range
Min: 0.96   Max: 1.74
Current: 0.97

0.96
1.74
Quick Ratio 0.46
ABC's Quick Ratio is ranked lower than
65% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. ABC: 0.46 )
ABC' s 10-Year Quick Ratio Range
Min: 0.37   Max: 0.71
Current: 0.46

0.37
0.71

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.22
ABC's Dividend Yield is ranked lower than
73% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.70 vs. ABC: 1.22 )
ABC' s 10-Year Dividend Yield Range
Min: 0.11   Max: 1.44
Current: 1.22

0.11
1.44
Dividend Payout 0.81
ABC's Dividend Payout is ranked higher than
62% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.81 vs. ABC: 0.81 )
ABC' s 10-Year Dividend Payout Range
Min: 0.02   Max: 1.38
Current: 0.81

0.02
1.38
Dividend growth (3y) 37.90
ABC's Dividend growth (3y) is ranked higher than
87% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.70 vs. ABC: 37.90 )
ABC' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 81.7
Current: 37.9

0
81.7
Yield on cost (5-Year) 6.12
ABC's Yield on cost (5-Year) is ranked higher than
87% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.06 vs. ABC: 6.12 )
ABC' s 10-Year Yield on cost (5-Year) Range
Min: 0.56   Max: 7.34
Current: 6.12

0.56
7.34
Share Buyback Rate 6.40
ABC's Share Buyback Rate is ranked higher than
97% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.10 vs. ABC: 6.40 )
ABC' s 10-Year Share Buyback Rate Range
Min: 10   Max: -30.6
Current: 6.4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.30
ABC's Price/DCF (Projected) is ranked higher than
73% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. ABC: 1.30 )
ABC' s 10-Year Price/DCF (Projected) Range
Min: 0.32   Max: 8.44
Current: 1.3

0.32
8.44
Price/Median PS Value 1.20
ABC's Price/Median PS Value is ranked higher than
62% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.30 vs. ABC: 1.20 )
ABC' s 10-Year Price/Median PS Value Range
Min: 0.52   Max: 2.08
Current: 1.2

0.52
2.08
Earnings Yield (Greenblatt) 3.80
ABC's Earnings Yield (Greenblatt) is ranked lower than
60% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.40 vs. ABC: 3.80 )
ABC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.8   Max: 16.8
Current: 3.8

3.8
16.8
Forward Rate of Return (Yacktman) 7.36
ABC's Forward Rate of Return (Yacktman) is ranked higher than
57% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.83 vs. ABC: 7.36 )
ABC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 6.6   Max: 30.3
Current: 7.36

6.6
30.3

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:MCK, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:ABG.Germany
AmerisourceBergen Corp is a Delaware Corporation and was formed in 2001. It is a pharmaceutical services company, with operations mainly in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, it provides drug distribution and related services designed to reduce costs and improve patient outcomes. The Company distributes a comprehensive offering of brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers mainly located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies, and other customers. The Company also provides pharmacy services to certain specialty drug patients. Additionally, it furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including pharmaceutical packaging, pharmacy automation, inventory management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. It currently serves its customers (healthcare providers, pharmaceutical manufacturers, and certain specialty drug patients) through a geographically diverse network of distribution service centers and other operations in the United States and Canada, and through packaging facilities in the United States and the United Kingdom. The Company's largest national competitors are Cardinal Health, Inc. (Cardinal) and McKesson Corporation (McKesson). It is subject to oversight by various federal and state governmental entities and it is subject to, and affected by, a variety of federal and state laws, regulations and policies.
» More Articles for ABC

Headlines

Articles On GuruFocus.com
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Weekly CEO Sells Highlight: AmerisourceBergen, Huntsman, Johnson Controls, Cigna, and Foster Wheeler Jun 15 2014 
Graham Holdings Taking Care of the Business Apr 11 2014 
Cardinal Health Inc. Dividend Stock Analysis Dec 13 2013 
Why Am I Staying Bullish on Walgreen? Nov 20 2013 
Quality, Capital Allocation, Value and Growth Aug 03 2013 
For a Healthier Portfolio - Look Here Jul 25 2013 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jun 28 2013 
Weekly CEO Sells Highlight: Texas Roadhouse Inc., Theravance Inc., AmerisourceBergen Corp. and Nuanc May 06 2013 
CASH FLOW HAS REMAIN Apr 14 2013 

More From Other Websites
AMERISOURCEBERGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Aug 19 2014
AMERISOURCEBERGEN CORP Financials Aug 15 2014
"Outside The Box" Deal Propels AmerisourceBergen Aug 08 2014
AMERISOURCEBERGEN CORP Files SEC form 10-Q, Quarterly Report Aug 07 2014
AmerisourceBergen Declares Quarterly Dividend Aug 07 2014
AmerisourceBergen Declares Quarterly Dividend Aug 07 2014
3 Stocks Pushing The Wholesale Industry Lower Aug 06 2014
Acquisition of own shares Aug 05 2014
Big Cap 20: Several Large Caps Act Well Post-Breakout Aug 04 2014
Largest option trades in equities Aug 04 2014
Cardinal Health Guides Low As Revenue Keeps Sliding Aug 04 2014
Acquisition of own shares Aug 04 2014
TAL Education, Team Health Join The IBD 50 Resistance Aug 01 2014
Acquisition of own shares Aug 01 2014
Acquisition of own shares Jul 31 2014
Acquisition of own shares Jul 30 2014
Acquisition of own shares Jul 29 2014
Acquisition of own shares Jul 28 2014
AmerisourceBergen Beats on Q3 Earnings & Revenues, Ups View Jul 24 2014
AmerisourceBergen Hits High As Walgreen Pact Lifts Q3 Jul 24 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide